Yahoo Finance Best ASX Growth Companies
Companies such as Propel Funeral Partners and Jumbo Interactive have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolio should consider these financially stable, high-growth stocks. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.
Propel Funeral Partners Limited (ASX:PFP)
Propel Funeral Partners Limited provides death care services in Australia and New Zealand. Founded in 2012, and run by CEO Albin Kurti, the company provides employment to 247 people and with the stock’s market cap sitting at AUD A$299.40M, it comes under the small-cap category.
PFP’s projected future profit growth is an exceptional 99.74%, with an underlying 51.67% growth from its revenues expected over the upcoming years. It appears that PFP’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 8.05%. PFP’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Want to know more about PFP? I recommend researching its fundamentals here.
Jumbo Interactive Limited (ASX:JIN)
Jumbo Interactive Limited engages in the retail of lottery tickets through Internet and mobile devices. Founded in 1995, and now run by Mike Veverka, the company employs 117 people and with the stock’s market cap sitting at AUD A$250.66M, it comes under the small-cap stocks category.
Extreme optimism for JIN, as market analysts projected an outstanding earnings growth rate of 15.77% for the stock, supported by a double-digit sales growth of 27.63%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 25.36%. JIN ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Interested to learn more about JIN? Take a look at its other fundamentals here.
Mayne Pharma Group Limited (ASX:MYX)
Mayne Pharma Group Limited manufactures and sells branded and generic pharmaceutical products worldwide. The company size now stands at 789 people and with the company’s market cap sitting at AUD A$1.39B, it falls under the small-cap group.
MYX is expected to deliver an extremely high earnings growth over the next couple of years of 99.41%, driven by a positive double-digit revenue growth of 16.32% and cost-cutting initiatives. Though some cost-cutting activities may artificially inflate margins, it appears that this isn’t solely the case here, as profit growth is also coupled with high top-line expansion. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 6.33%. MYX ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Interested to learn more about MYX? Other fundamental factors you should also consider can be found here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
